Advances and challenges in therapeutic targeting of NRF2

Dinkova-Kostova, Albena T and Copple, Ian M ORCID: 0000-0003-4101-1913 (2023) Advances and challenges in therapeutic targeting of NRF2. TRENDS IN PHARMACOLOGICAL SCIENCES, 44 (3). pp. 137-149.

Access the full-text of this item by clicking on the Open Access link.

Official URL: http://dx.doi.org/10.1016/j.tips.2022.12.003

Abstract

Activation of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) is emerging as an attractive therapeutic approach to counteract oxidative stress, inflammation, and metabolic imbalances. These processes underpin many chronic pathologies with unmet therapeutic needs, including neurodegenerative disorders and metabolic diseases. As the NRF2 field transitions into the clinical phase of its evolution, the need for an understanding of the factors influencing NRF2 pharmacology has never been greater. In this opinion article we describe the rationale for targeting NRF2, summarise the recent advances in drug development of NRF2 modulators, and reflect on the remaining challenges in realising the full clinical potential of NRF2 as a therapeutic target.

Item Type:	Article
Uncontrolled Keywords:	Humans, Inflammation, Oxidative Stress, NF-E2-Related Factor 2, Molecular Targeted Therapy, Kelch-Like ECH-Associated Protein 1, Drug Development
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	21 Feb 2023 16:02
Last Modified:	29 Sep 2023 02:39
DOI:	10.1016/j.tips.2022.12.003
Open Access URL:	https://doi.org/10.1016/j.tips.2022.12.003
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3168499